Publication

The current total economic burden of diabetes mellitus in the Netherlands

Peters, M. L., Huisman, E. L., Schoonen, M. & Wolffenbuttel, B. H. R., Sep-2017, In : The Netherlands Journal of Medicine. 75, 7, p. 281-297 17 p.

Research output: Contribution to journalReview articleAcademicpeer-review

APA

Peters, M. L., Huisman, E. L., Schoonen, M., & Wolffenbuttel, B. H. R. (2017). The current total economic burden of diabetes mellitus in the Netherlands. The Netherlands Journal of Medicine, 75(7), 281-297.

Author

Peters, M L ; Huisman, E L ; Schoonen, M ; Wolffenbuttel, B H R. / The current total economic burden of diabetes mellitus in the Netherlands. In: The Netherlands Journal of Medicine. 2017 ; Vol. 75, No. 7. pp. 281-297.

Harvard

Peters, ML, Huisman, EL, Schoonen, M & Wolffenbuttel, BHR 2017, 'The current total economic burden of diabetes mellitus in the Netherlands' The Netherlands Journal of Medicine, vol. 75, no. 7, pp. 281-297.

Standard

The current total economic burden of diabetes mellitus in the Netherlands. / Peters, M L; Huisman, E L; Schoonen, M; Wolffenbuttel, B H R.

In: The Netherlands Journal of Medicine, Vol. 75, No. 7, 09.2017, p. 281-297.

Research output: Contribution to journalReview articleAcademicpeer-review

Vancouver

Peters ML, Huisman EL, Schoonen M, Wolffenbuttel BHR. The current total economic burden of diabetes mellitus in the Netherlands. The Netherlands Journal of Medicine. 2017 Sep;75(7):281-297.


BibTeX

@article{5b5d926761a845e685f5cfa656a33df2,
title = "The current total economic burden of diabetes mellitus in the Netherlands",
abstract = "INTRODUCTION AND AIM: Insight into the total economic burden of diabetes mellitus (DM) is essential for decision makers and payers. Currently available estimates for the Netherlands only include part of the total burden or are no longer up-to-date. Therefore, this study aimed to determine the current total economic burden of DM and its complications in the Netherlands, by including all the relevant cost components.METHODS: The study combined a systematic literature review to identify all relevant published information and a targeted review to identify relevant information in the grey literature. The identified evidence was then combined to estimate the current total economic burden.RESULTS: In 2016, there were an estimated 1.1 million DM patients in the Netherlands, of whom approximately 10{\%} had type 1 and 90{\%} had type 2 DM. The estimated current total economic burden of DM was € 6.8 billion in 2016. Healthcare costs (excluding costs of complications) were € 1.6 billion, direct costs of complications were € 1.3 billion and indirect costs due to productivity losses, welfare payments and complications were € 4.0 billion.CONCLUSION: DM and its complications pose a substantial economic burden to the Netherlands, which is expected to rise due to changing demographics and lifestyle. Indirect costs, such as welfare payments, accounted for a large portion of the current total economic burden of DM, while these cost components are often not included in cost estimations. Publicly available data for key cost drivers such as complications were scarce.",
keywords = "Cost of Illness, Diabetes Complications/economics, Diabetes Mellitus/economics, Female, Health Care Costs/statistics & numerical data, Humans, Incidence, Male, Netherlands/epidemiology, Prevalence",
author = "Peters, {M L} and Huisman, {E L} and M Schoonen and Wolffenbuttel, {B H R}",
year = "2017",
month = "9",
language = "English",
volume = "75",
pages = "281--297",
journal = "The Netherlands Journal of Medicine",
issn = "0300-2977",
publisher = "van Zuiden Communications BV.",
number = "7",

}

RIS

TY - JOUR

T1 - The current total economic burden of diabetes mellitus in the Netherlands

AU - Peters, M L

AU - Huisman, E L

AU - Schoonen, M

AU - Wolffenbuttel, B H R

PY - 2017/9

Y1 - 2017/9

N2 - INTRODUCTION AND AIM: Insight into the total economic burden of diabetes mellitus (DM) is essential for decision makers and payers. Currently available estimates for the Netherlands only include part of the total burden or are no longer up-to-date. Therefore, this study aimed to determine the current total economic burden of DM and its complications in the Netherlands, by including all the relevant cost components.METHODS: The study combined a systematic literature review to identify all relevant published information and a targeted review to identify relevant information in the grey literature. The identified evidence was then combined to estimate the current total economic burden.RESULTS: In 2016, there were an estimated 1.1 million DM patients in the Netherlands, of whom approximately 10% had type 1 and 90% had type 2 DM. The estimated current total economic burden of DM was € 6.8 billion in 2016. Healthcare costs (excluding costs of complications) were € 1.6 billion, direct costs of complications were € 1.3 billion and indirect costs due to productivity losses, welfare payments and complications were € 4.0 billion.CONCLUSION: DM and its complications pose a substantial economic burden to the Netherlands, which is expected to rise due to changing demographics and lifestyle. Indirect costs, such as welfare payments, accounted for a large portion of the current total economic burden of DM, while these cost components are often not included in cost estimations. Publicly available data for key cost drivers such as complications were scarce.

AB - INTRODUCTION AND AIM: Insight into the total economic burden of diabetes mellitus (DM) is essential for decision makers and payers. Currently available estimates for the Netherlands only include part of the total burden or are no longer up-to-date. Therefore, this study aimed to determine the current total economic burden of DM and its complications in the Netherlands, by including all the relevant cost components.METHODS: The study combined a systematic literature review to identify all relevant published information and a targeted review to identify relevant information in the grey literature. The identified evidence was then combined to estimate the current total economic burden.RESULTS: In 2016, there were an estimated 1.1 million DM patients in the Netherlands, of whom approximately 10% had type 1 and 90% had type 2 DM. The estimated current total economic burden of DM was € 6.8 billion in 2016. Healthcare costs (excluding costs of complications) were € 1.6 billion, direct costs of complications were € 1.3 billion and indirect costs due to productivity losses, welfare payments and complications were € 4.0 billion.CONCLUSION: DM and its complications pose a substantial economic burden to the Netherlands, which is expected to rise due to changing demographics and lifestyle. Indirect costs, such as welfare payments, accounted for a large portion of the current total economic burden of DM, while these cost components are often not included in cost estimations. Publicly available data for key cost drivers such as complications were scarce.

KW - Cost of Illness

KW - Diabetes Complications/economics

KW - Diabetes Mellitus/economics

KW - Female

KW - Health Care Costs/statistics & numerical data

KW - Humans

KW - Incidence

KW - Male

KW - Netherlands/epidemiology

KW - Prevalence

M3 - Review article

VL - 75

SP - 281

EP - 297

JO - The Netherlands Journal of Medicine

JF - The Netherlands Journal of Medicine

SN - 0300-2977

IS - 7

ER -

ID: 77222184